MRK
Merck & Company, Inc. · Healthcare · Drug Manufacturers - General
TECHNeutralZACKSHold
R500#224 today
$144.30
+0.34% today · -3.01% 1W
Oct 2 close or latest
PreviewWhy it's moving
Moving with the market
- MRK +0.34% on the last session vs SPY +0.74%: −0.4 pts of stock-specific move.
- Aftermath, big drop (Sep 30): After its 71 big drops in the past 5 years, MRK typically gained 1.5% over the next month (median) and was higher 58% of the time; half the outcomes fell between -2.3% and +4.8%. An ordinary month: +1.3%. Among S&P 500 stocks after big drops, that ranks #263 of 500.
- Market backdrop (Fri): Average Hourly Earnings m/m 0.1% vs 0.3% expected (cooler); Non-Farm Employment Change 29K vs 89K expected (weaker); S&P futures +0.41%, 10-year yield -5bp in the 30 minutes after.
Assembled from Wallsti's own signals.
Next report
Oct 29
Before the open · in 25 days
EPS estimate
$2.19
$1.80 to $2.34 · 18 analysts
Revenue estimate
$17.3B
$16.9B to $17.7B
Track record
7/8 beats
last 8 reports · moved ±2.4% on average
Reports
| Reported | Quarter | EPS est. | EPS | EPS surprise | Revenue | Reaction | Gap | 5 days |
|---|---|---|---|---|---|---|---|---|
| Aug 4, 2026 BMO | 2Q2026 | −$0.26 | −$0.13 | +$0.13 (+49.4%) beat | $16.6B | +0.2% -1.6 vs SPY | +0.5% | +2.5% |
| Apr 30, 2026 BMO | 1Q2026 | −$1.47 | −$1.28 | +$0.19 (+13.2%) beat | $16.3B | -1.6% -2.6 vs SPY | -1.4% | +2.4% |
| Feb 3, 2026 BMO | 4Q2025 | $2.01 | $2.04 | +$0.03 (+1.5%) beat | $16.4B | +2.2% +3.0 vs SPY | -1.5% | +3.8% |
| Oct 30, 2025 BMO | 3Q2025 | $2.35 | $2.58 | +$0.23 (+9.9%) beat | $17.3B | -0.3% +0.8 vs SPY | -2.3% | -2.5% |
| Jul 29, 2025 BMO | $2.03 | $2.13 | +$0.10 (+4.9%) beat | — | -1.7% -1.4 vs SPY | -5.0% | -5.0% | |
| Apr 24, 2025 BMO | $2.14 | $2.22 | +$0.08 (+3.7%) beat | — | +1.4% -0.7 vs SPY | -0.6% | +8.2% | |
| Feb 4, 2025 BMO | $1.67 | $1.72 | +$0.05 (+3.0%) beat | — | -9.1% -9.7 vs SPY | -10.8% | -13.4% | |
| Oct 31, 2024 BMO | $1.57 | $1.57 | $0.00 (0.0%) in line | — | -2.4% -0.4 vs SPY | -3.7% | -3.9% | |
| Jul 30, 2024 BMO | $2.14 | $2.28 | +$0.14 (+6.5%) beat | — | -9.8% -9.3 vs SPY | -3.4% | -12.1% | |
| Apr 25, 2024 BMO | $1.92 | $2.07 | +$0.15 (+7.8%) beat | — | +2.9% +3.3 vs SPY | +2.1% | +1.4% | |
| Feb 1, 2024 BMO | −$0.11 | $0.03 | +$0.14 (>+100%) beat | — | +4.6% +3.3 vs SPY | +2.4% | +5.5% | |
| Oct 26, 2023 BMO | $1.95 | $2.13 | +$0.18 (+9.2%) beat | — | +1.9% +3.0 vs SPY | -0.5% | -0.8% | |
| Aug 1, 2023 BMO | −$2.18 | −$2.06 | +$0.12 (+5.5%) beat | — | -1.3% -1.0 vs SPY | +2.8% | -0.5% | |
| Apr 27, 2023 BMO | $1.34 | $1.40 | +$0.06 (+4.5%) beat | — | +1.5% -0.5 vs SPY | +1.0% | +4.2% | |
| Feb 2, 2023 BMO | $1.54 | $1.62 | +$0.08 (+5.2%) beat | — | -3.3% -4.8 vs SPY | -2.8% | -0.3% | |
| Oct 27, 2022 BMO | $1.71 | $1.85 | +$0.14 (+8.2%) beat | — | +1.4% +1.9 vs SPY | +1.4% | +1.0% | |
| Jul 28, 2022 BMO | $1.71 | $1.87 | +$0.16 (+9.4%) beat | — | -1.4% -2.7 vs SPY | -0.2% | -4.0% | |
| Apr 28, 2022 BMO | $1.83 | $2.14 | +$0.31 (+16.9%) beat | — | +4.9% +2.4 vs SPY | +1.6% | +4.9% | |
| Feb 3, 2022 BMO | $1.52 | $1.80 | +$0.28 (+18.4%) beat | — | -3.7% -1.3 vs SPY | -0.4% | -6.7% | |
| Oct 28, 2021 BMO | $1.55 | $1.75 | +$0.20 (+12.9%) beat | — | +6.1% +5.2 vs SPY | +2.3% | +8.8% | |
| Jul 29, 2021 BMO | $1.35 | $1.31 | −$0.04 (−3.0%) miss | — | — | — | — | |
| Apr 29, 2021 BMO | $1.61 | $1.40 | −$0.21 (−13.0%) miss | — | — | — | — | |
| Feb 4, 2021 BMO | $1.39 | $1.32 | −$0.07 (−5.0%) miss | — | — | — | — | |
| Oct 27, 2020 BMO | $1.43 | $1.74 | +$0.31 (+21.7%) beat | — | — | — | — |
BMO = before the open, AMC = after the close. Reaction: the first session that could trade on the report (the same day for BMO, the next session for AMC) against the close before it; "vs SPY" subtracts the S&P 500 over the same session. EPS surprise is in dollars, with the percentage only when the estimate is at least $0.10 (near zero, a small beat would show as hundreds of percent). Revenue surprise needs the estimate from before the report, so it starts with the reports Wallsti saw coming.
Analyst estimates
| Period | EPS | Range | vs year ago | 90-day trend | Revisions 30d | Revenue | vs year ago |
|---|---|---|---|---|---|---|---|
| Current quarter · Sep 30, 2026 | $2.19 (18) | $1.80 – $2.34 | -15% | -4.5% | ▲1 ▼1 | $17.3B | 0% |
| Next quarter · Dec 31, 2026 | $1.96 (18) | $1.82 – $2.25 | -4% | +1.1% | ▲1 ▼2 | $16.9B | +3% |
| Current year · Dec 31, 2026 | $2.73 (25) | $2.61 – $2.83 | -70% | +0.6% | ▲2 ▼2 | $67.1B | +3% |
| Next year · Dec 31, 2027 | $9.49 (24) | $8.41 – $10.36 | +247% | -1.1% | ▲6 ▼2 | $70.2B | +5% |
Consensus as of Oct 4, 2026. Source: Yahoo Finance analyst estimates; schedule and timing also from Nasdaq's earnings calendar.